Ginkgo Bioworks, Inc.

Businessfiled

Ginkgo Bioworks, Inc. operates in Other, based in BOSTON.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Ginkgo Bioworks, Inc. has raised $102M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $52M on 2015-07-08.

Most recent recorded round closed around 2015-07-08.

Valuation (modeled)modeled

Provath models Ginkgo Bioworks, Inc. at approximately $885M (range $200M–$2.3B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.03× the median modeled value of Series C Other companies in 2013–2015 (148 peers) — value vs value, same stage and era. Within the normal band (103% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 11.0 yr ago; this sector typically re-raises about every 11 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 96% of Other peers (25015 compared).

Modeled value ranks above 96% of those peers.

Closest niche peers: Island Timberlands Finance Corp, Layne Christensen Co, Autotask Superior Holding, Inc., Creative Artists Agency Holdings LLC, Concord Resources Ltd.

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.